0000939767-17-000117.txt : 20170526 0000939767-17-000117.hdr.sgml : 20170526 20170526205336 ACCESSION NUMBER: 0000939767-17-000117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170525 FILED AS OF DATE: 20170526 DATE AS OF CHANGE: 20170526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Julie CENTRAL INDEX KEY: 0001557928 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 17875390 MAIL ADDRESS: STREET 1: C/O RAPTOR PHARMACEUTICAL CORP STREET 2: 9 COMMERCIAL BLVD, SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 4 1 wf-form4_149584640178321.xml FORM 4 X0306 4 2017-05-25 0 0000939767 EXELIXIS, INC. EXEL 0001557928 Smith Julie C/O EXELIXIS, INC. 210 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Option (right to buy) 19.57 2017-05-25 4 A 0 23491 0 A 2017-05-25 2024-05-24 Common Stock 23491.0 23491 D Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Jeffrey J. Hessekiel, Attorney in Fact 2017-05-26